The objective of this study was to evaluate the short- and long-term outcomes of adult patients with solid tumors receiving chemotherapy in the intensive care unit (ICU).
This was a retrospective single-center study comparing the outcomes of patients with solid tumors who received chemotherapy in the ICU with a matched cohort of ICU patients (by age, sex, and tumor type) who did not receive chemotherapy. Conditional logistic regression and shared frailty Cox regression were used to assess short-term (ICU and hospital) mortality and death by 12-month post-hospital discharge, respectively.
Seventy-three patients with solid tumors who received chemotherapy in the ICU were successfully matched. The most common solid tumors included thoracic (30%), genitourinary (26%), and breast (16%). The ICU, hospital, and 12-month (post discharge) mortality rates of patients who recieved chomtherapy in the ICU were 23%, 36%, and 43%, respectively. When compared to the matched cohort of patients who did not receive chemotherapy, patients who received chemotherapy had a significantly longer length of stay in the ICU (median 7 vs. 4 days, p < 0.001) and hospital (median 15 vs. 11 days, p = 0.011) but similar short-term ICU and hospital mortality rates (23% vs. 18% and 36% vs. 38%, respectively). Patients who received chemotherapy in the ICU were at a lower risk of death by 12 months (HR 0.31, p < 0.001) compared to the matched cohort on multivariable analysis.
Patients with solid tumors who received chemotherapy had increased ICU and hospital length of stay compared to patients who did not. Although short-term mortality did not differ, patients who received chemotherapy in the ICU had improved long-term survival. Our data can inform critical care triage decisions to include patients who are to receive chemotherapy in the ICU.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Supplemental digital content is available for this article.
Puxty K, McLoone P, Quasim T (2015) Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA Oncol 1(8):1078–1085
Shimabukuro-Vornhagen A, Boll B, Kochanek M, Azoulay E, von Bergwelt-Baildon MS (2016) Critical care of patients with cancer. CA Cancer J Clin 66:496–517
Wigmore T, Farquhar-Smith P (2016) Outcomes for critically ill cancer patients in the ICU: current trends and prediction. Int Anesthesiol Clin 54(4):e62–e75
Bos MM, Verburg IW, Dumaij I, Stouthard J, Nortier JW, Richel D, van der Zwan E, de Keizer NF, de Jonge E (2015) Intensive care admission of cancer patients: a comparative analysis. Cancer Med 4(7):966–976
Torres VB, Vassalo J, Silva UV, Caruso P, Torelly AP, Silva E, Teles JM, Knibel M, Rezende E, Netto JJ, Piras C, Azevedo LC, Bozza FA, Spector N, Salluh JI, Soares M (2016) Outcomes in critically ill patients with cancer-related complications. PLoS One 11(10):e0164537
Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40(10):1570–1572
Zerbib Y, Rabbat A, Fartoukh M, et al; Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (GRRR-OH). Urgent chemotherapy for life-threatening complications related to solid neoplasms. Crit Care Med 2017;45(7):e640-e648
de Oliveira MCF, Ferreira JC, Nassar Junior AP, Dettino ALA, Caruso P (2017) Impact of urgent chemotherapy in critically ill patients. J Intensive Care Med 885066617748602
Chen YF, Lin JW, Ho CC, Yang CY, Chang CH, Huang TM, Chen CY, Chen KY, Shih JY, Yu CJ (2017) Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit. J Cancer 8(11):1995–2003
Hsia TC, Tu CY, Chen HJ (2014) The impact of rescue or maintenance therapy with EGFR TKIs for stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation. BMC Anesthesiol 14:55
Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, le Gall JR, Schlemmer B, Azoulay E (2005) Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 33(11):2488–2493
Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K (2011) Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 19(4):491–495
Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlström A, Riss K, Rabitsch W, Bojic M, Knoebl P, Locker GJ, Obiditsch M, Fuhrmann V, Schellongowski P, Arbeitsgruppe für hämato-onkologische Intensivmedizin der Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin (ÖGIAIN) (2014) Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 93(10):1629–1636
Charlson ME, Pompei P, Ales KL, MacKenzie C (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Schoenfeld D (2006) Survival methods, including those using competing risks analysis, are not appropriate for intensive care unit outcome studies. Crit Care 10(1):103
Pastores SM, Goldman DA, Shaz DJ, Kostelecky N, Daley RJ, Peterson TJ, Tan KS, Halpern NA (2018) Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit. Cancer 124(14):3025–3036
Bergwelt-Baildon M, Hallek MJ, Shimabukuro-Vornhagen AA, Kochanek M (2010) CCC meets ICU: redefining the role of critical care of cancer patients. BMC Cancer 10:612
We acknowledge the assistance of Gleb Kirnicinii, Senior Application Analyst, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY for data management and pre-analysis.
This study was supported, in part, by the Core Grant (P30 CA008748) and the Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
The authors have full control of all primary data and agree to allow the journal to review their data if requested. All authors had full access to all the data (including statistical reports and tables) in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Shaz, D.J., Pastores, S.M., Goldman, D.A. et al. Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit. Support Care Cancer 28, 3855–3865 (2020). https://doi.org/10.1007/s00520-019-05226-w
- Solid tumors
- Intensive care unit